Formulation Development and Evaluation of Dextran Nanoparticles Enclosed with Recombinant Typhoid (Ty21a) Antigen

Authors

  • Prajapati R. School of pharmacy, SunRise University, Alwar, Rajasthan 301028
  • Babar V. B. School of pharmacy, SunRise University, Alwar, Rajasthan 301028

DOI:

https://doi.org/10.61554/ijnrph.v1i2.2023.44

Abstract

Developing efficacious vaccines for Typhoid fever continues to be a paramount concern in global health, particularly in areas with a significant prevalence of the illness. This research focused on the synthesis, refinement, and analysis of recombinant Typhoid (Ty21a) antigen-encapsulated Eudragit-coated dextran nanoparticles. These nanoparticles function as an innovative platform for delivering the Ty21a antigen, which has the potential to enhance vaccination durability and effectiveness. The synthesis process was methodically adjusted to get optimal nanoparticle size, shape, and surface qualities by manipulating several formulation factors. The physicochemical evaluation verified the generation of precisely specified nanoparticles that effectively encapsulate the Ty21a antigen. The in vitro release assays shown that the Eudragit-coated nanoparticles can release antigens in a sustained and regulated manner, suggesting that they have the ability to provide prolonged immune activation. This study demonstrates the potential of using recombinant Typhoid antigen-encapsulated Eudragit-coated dextran nanoparticles as a promising platform for advanced vaccines. This platform offers improved ability to stimulate an immune response and controlled delivery of the antigen. These findings have significant implications for global health efforts focused on preventing Typhoid fever.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Antigen, Controlled release, Immunogenicity, Optimization. Nanoparticles, Vaccine

Downloads

Published

2023-12-30

How to Cite

R., P., & V. B., B. (2023). Formulation Development and Evaluation of Dextran Nanoparticles Enclosed with Recombinant Typhoid (Ty21a) Antigen. International Journal of Newgen Research in Pharmacy & Healthcare, 1(2), 1–7. https://doi.org/10.61554/ijnrph.v1i2.2023.44

Issue

Section

Articles

References

Manukyan H, Wahid R, Ansari A, Tritama E, Macadam A, Konz J, et al. Quantitative RT-PCR assays for quantification of undesirable mutants in the novel type 2 oral Poliovirus vaccine. Vaccines (Basel) [Internet]. 2022;10(9):1394. Available from: http://dx.doi.org/10.3390/vaccines10091394 DOI: https://doi.org/10.3390/vaccines10091394

Kowalska JD, Lara M, Hlebowicz M, Mularska E, Jabłonowska E, Siwak E, et al. Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland. Infection [Internet]. 2023;51(2):379–87. Available from: http://dx.doi.org/10.1007/s15010-022-01887-8 DOI: https://doi.org/10.1007/s15010-022-01887-8

Schlievert PM. Staphylococcal enterotoxin B and C mutants and vaccine toxoids. Microbiol Spectr [Internet]. 2023;e0444622. Available from: http://dx.doi.org/10.1128/spectrum.04446-22 DOI: https://doi.org/10.1128/spectrum.04446-22

Pandey SP, Bhaskar R, Han SS, Narayanan KB. Autoimmune responses and therapeutic interventions for systemic lupus erythematosus: a comprehensive review. Endocr Metab Immune Disord Drug Targets [Internet]. 2023; Available from: http://dx.doi.org/10.2174/1871530323666230915112642 DOI: https://doi.org/10.2174/1871530323666230915112642

Gaied H, In process control manager of diphtheria and tetanus plant, the holding company for the production of vaccines, sera and drugs (vacsera). Antiviral activity of secondary metabolites produced by Streptomyces species isolated from Egyptian soil. Int J Adv Res (Indore) [Internet]. 2017;5(5):1165–74. Available from: http://dx.doi.org/10.21474/ijar01/4227 DOI: https://doi.org/10.21474/IJAR01/4227

Tkachenko A, Özdemir S, Tollu G, Dizge N, Ocakoglu K, Prokopiuk V, et al. Antibacterial and antioxidant activity of gold and silver nanoparticles in dextran-polyacrylamide copolymers. Biometals [Internet]. 2023; Available from: http://dx.doi.org/10.1007/s10534-023-00532-7 DOI: https://doi.org/10.1007/s10534-023-00532-7

Bradford EL, Gregory CL, Roman Longoria A, Jones KR, Bueren EK, Haak DC, et al. A new duplex qPCR assay for the quantification of honey bee (Apis mellifera) parasites Nosema ceranae and Nosema apis tested with low dose experimental exposure. J Apic Res [Internet]. 2022;1–12. Available from: http://dx.doi.org/10.1080/00218839.2022.2083846 DOI: https://doi.org/10.1080/00218839.2022.2083846

Blanco-Cabra N, Movellan J, Marradi M, Gracia R, Salvador C, Dupin D, et al. Neutralization of ionic interactions by dextran-based single-chain nanoparticles improves tobramycin diffusion into a mature biofilm. NPJ Biofilms Microbiomes [Internet]. 2022;8(1):52. Available from: http://dx.doi.org/10.1038/s41522-022-00317-9 DOI: https://doi.org/10.1038/s41522-022-00317-9

Elmowafy M, Shalaby K, Elkomy MH, Alsaidan OA, Gomaa HAM, Hendawy OM, et al. Exploring the potential of quercetin/aspirin-loaded chitosan nanoparticles coated with Eudragit L100 in the treatment of induced-colorectal cancer in rats. Drug Deliv Transl Res [Internet]. 2023;13(10):2568–88. Available from: http://dx.doi.org/10.1007/s13346-023-01338-3 DOI: https://doi.org/10.1007/s13346-023-01338-3

Hosseini S, Wey K, Epple M. Enteric coating systems for the oral administration of bioactive calcium phosphate nanoparticles carrying nucleic acids into the colon. ChemistrySelect [Internet]. 2020;5(31):9720–9. Available from: http://dx.doi.org/10.1002/slct.202002846 DOI: https://doi.org/10.1002/slct.202002846

Solís-Cruz GY, Alvarez-Roman R, Rivas-Galindo VM, Galindo-Rodríguez SA, Silva-Mares DA, Marino-Martínez IA, et al. Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity. Acta Pharm [Internet]. 2023;73(3):457–73. Available from: http://dx.doi.org/10.2478/acph-2023-0028 DOI: https://doi.org/10.2478/acph-2023-0028

Krishna SR, Ramu A, Vidyadhara S. Study of influence of formulation and process variables on entrapment efficiency and particle size of floating micro balloons of dipyridamole by doe. Int J Pharm Pharm Sci [Internet]. 2020;85–91. Available from: http://dx.doi.org/10.22159/ijpps.2020v12i10.35995 DOI: https://doi.org/10.22159/ijpps.2020v12i10.35995

Parashar AK, Patel P, Gupta AK, Jain NK, Kurmi BD. Synthesis, characterization andin vivoEvaluation of PEGylated PPI dendrimer for safe and prolonged delivery of insulin. Drug Deliv Lett [Internet]. 2019;9(3):248–63. Available from: http://dx.doi.org/10.2174/2210303109666190401231920 DOI: https://doi.org/10.2174/2210303109666190401231920

Parashar AK, Patel P, Kaurav M, Yadav K, Singh D, Gupta GD, et al. Nanomaterials as Diagnostic Tools and Drug Carriers. In: Nanoparticles and Nanocarriers-Based Pharmaceutical Formulations. Bentham Science Publishers; 2022. p. 126–56. DOI: https://doi.org/10.2174/9789815049787122010007

Yadav P, Yadav AB. Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system. Futur J Pharm Sci [Internet]. 2021;7(1). Available from: http://dx.doi.org/10.1186/s43094-021-00345-w DOI: https://doi.org/10.1186/s43094-021-00345-w

Parashar AK. Synthesis and characterization of temozolomide loaded theranostic quantum dots for the treatment of brain glioma. J Med Pharm Allied Sci [Internet]. 2021;10(3):2778–82. Available from: http://dx.doi.org/10.22270/jmpas.v10i3.1073 DOI: https://doi.org/10.22270/jmpas.v10i3.1073